Get the tools used by (smart)² investors.

Watchlists Ideas Screener Data Explorer Charts Saved Work

Net Income to Common Excl Extra Items for Enanta Pharmaceuticals Inc

Join now and get access to the full platform

Search for company or ETF

0 results available. Select is focused ,type to refine list, press Down to open the menu,

ENTA: Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company’s product pipeline comprises ED...

- USD

Price

– USD

Fair Value

–

Upside

- - -

52-week range

Create Chart Create Model Add To Watchlist

Analysis

Fiscal Years

Trailing Twelve Months

Fiscal Halfs

Fiscal Quarters

Daily

Hide this widget

The following section summarizes insights on Enanta Pharmaceuticals Inc's Net Income to Common Excl Extra Items:

Performance Summary

Enanta Pharmaceuticals's latest twelve months net income to common excl extra items is -104.9 million
Enanta Pharmaceuticals's net income to common excl extra items for fiscal years ending September 2020 to 2024 averaged -97.356 million.
Enanta Pharmaceuticals's operated at median net income to common excl extra items of -116 million from fiscal years ending September 2020 to 2024.
Looking back at the last 5 years, Enanta Pharmaceuticals's net income to common excl extra items peaked in September 2020 at -36.168 million.
Enanta Pharmaceuticals's net income to common excl extra items hit its 5-year low in September 2023 of -133.8 million.
Enanta Pharmaceuticals's net income to common excl extra items decreased in 2020 (-36.168 million, -178.0%), 2021 (-78.996 million, +118.4%), 2022 (-121.8 million, +54.1%), and 2023 (-133.8 million, +9.9%) and increased in 2024 (-116 million, -13.3%).

Benchmarks

Metric Usage: Net Income to Common Excl Extra Items

Hide this widget

ni_avail_excl

Slug

number

Datatype

text

Format

current

Default Period

FY, Q, LTM, YTD

Periods Supported

Free

Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Net Income to Common Excl Extra Items in the financials category include:

Current Taxes - This item represents the current amount of income taxes payable, both domestic and foreign.
Owner Earnings - A measure of free cash flow made famous by Warren Buffett when he wrote about it in Berkshire Hathaway's annual report in 1986. Mr. Buffett stated that the value of a company is the present value of owner earnings expected to occur over the life of a business, less any reinvestment of earnings.
Other Investing Activities - This item represents all other investing cash flows not included in any specific data item.
Current Income Taxes Payable - This item represents the accrued portion of Income taxes levied on the Corporate Income. If Income Taxes are combined with any other taxes or any other liabilities, where income taxes appear as first string and the company does not report the break up for the same, then the same will form part of this data item only.

View Full List

Search for metric or datapoint

Net Income to Common Excl Extra Items

Represents the net income or loss available to common stockholders and is arrived after adjusting preferred stock dividends and other adjustments to n...

Definition of Net Income to Common Excl Extra Items

Sector Benchmark Analysis

Sector

Industry Group

Industry

Hide this widget

The chart above depicts the distribution of net income to common excl extra items for companies operating in the Healthcare sector in the Developed economic region. Over 2,380 companies were considered in this analysis, and 2,288 had meaningful values. The average net income to common excl extra items of companies in the sector is -1.139 M with a standard deviation of 147.6 M.

Enanta Pharmaceuticals Inc's Net Income to Common Excl Extra Items of -104.9 M ranks in the 9.3% percentile for the sector. The following table provides additional summary stats:

Net Income to Common Excl Extra Items In The Healthcare Sector
Economic Risk Region	Developed
Total Constituents	2,384
Included Constituents	2,288
Min	-382.7 M
Max	1.32 B
Median	-5.27 M
Mean	-1.139 M
Standard Deviation	147.6 M

You can find companies with similar net income to common excl extra items using this stock screener.